Regulation2 min read

White House Accelerates Cannabis Rescheduling Timeline

Biden administration signals imminent federal cannabis policy shift, potentially moving marijuana from Schedule I to Schedule III classification.

April 23, 2026 at 4:02 AMCannabismarketcap

The Biden administration intensifies efforts to reschedule cannabis at the federal level, with White House officials indicating the Drug Enforcement Administration will finalize its rescheduling decision within weeks rather than months. The move would shift marijuana from Schedule I to Schedule III under the Controlled Substances Act, marking the most substantial federal cannabis policy reform in decades.

The rescheduling timeline acceleration comes as the administration faces mounting pressure from Democratic lawmakers and cannabis industry stakeholders ahead of the 2024 election cycle. Moving cannabis to Schedule III would maintain federal prohibition but acknowledge accepted medical use, allowing state-licensed operators to claim standard business tax deductions currently blocked under Section 280E of the tax code.

Multi-state operators stand to benefit most from the tax relief, with companies like Curaleaf, Green Thumb Industries, and Trulieve collectively paying hundreds of millions in additional taxes annually due to 280E restrictions. Industry analysts estimate rescheduling could improve operating margins by 15-25% for major cannabis companies, though interstate commerce and banking restrictions would remain unchanged.

The policy shift faces inevitable legal challenges from prohibition advocates and could trigger additional state-level reforms as federal and state cannabis laws continue diverging. Republican-controlled states maintain strict prohibition while Democratic states expand adult-use programs, creating a complex regulatory patchwork that rescheduling alone cannot resolve.

Canadian cannabis companies with U.S. exposure through licensing deals and management agreements also monitor the development closely, as rescheduling could accelerate institutional investment in U.S. cannabis assets currently restricted by federal prohibition. The timeline suggests a final decision before the November election, positioning cannabis reform as a key Democratic campaign issue targeting younger voters in swing states.